Actively Recruiting
Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer
Led by National Cancer Institute, Egypt · Updated on 2026-01-27
70
Participants Needed
1
Research Sites
18 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.
CONDITIONS
Official Title
Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years and 64 65 years old
- American Society of Anesthesiologists (ASA) physical status II-III
- Body mass index between 18 and 35 kg/m2
- Patients scheduled for thoracotomy surgery for lung cancer
You will not qualify if you...
- Patient refusal to participate
- History of sensitivity to local anesthetics
- History of psychological disorders
- Contraindications to regional anesthesia such as local infection, peripheral neuropathies, or blood clotting problems
- Severe respiratory, cardiac, liver, or kidney disease
- Morbid obesity
- Uncooperative patients
- Patients currently on chronic pain therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cairo University
Cairo, Egypt, 12613
Actively Recruiting
Research Team
M
Mai M Elrawas, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here